Multi-Omics for Maternal Health After Preeclampsia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-50
SponsorUniversity of California, San Diego
About this trial
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
Eligibility criteria
Qualifiers
Pregnant women 18 years of age to 50 years of age
10-24 weeks gestation at time of enrollment
Singleton pregnancy
Planning to deliver at a study site (UCSD or VUMC)
Disqualifiers
Inability to give informed consent
Intrauterine fetal demise
Fetal genetic or structural anomaly
Institutionalization for psychiatric disorder, mental deficiency or incarcerated
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,100 Participants
are grouped into 2 trial groupsSponsors and collaborators
University of California, San Diego
Lead sponsor
National Human Genome Research Institute (NHGRI)
Collaborator
Vanderbilt University Medical Center
Collaborator
Source ClinicalTrials.gov